Endexx Corp
OTC:EDXC
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.0007
0.0095
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
ROA
Return on Assets (ROA) measures how efficiently a company uses its assets to generate profit. It shows how much net income is earned for each dollar of assets.
Return on Assets (ROA) measures how efficiently a company uses its assets to generate profit. It shows how much net income is earned for each dollar of assets.
Peer Comparison
| Country | Company | Market Cap | ROA | ||
|---|---|---|---|---|---|
| US |
|
Endexx Corp
OTC:EDXC
|
514.7k USD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
972.2B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
547.5B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
277.1B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
209.4B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
219B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
272.1B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.7T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
148.3B USD |
Loading...
|
|
| FR |
|
Sanofi SA
PAR:SAN
|
93.8B EUR |
Loading...
|
Market Distribution
| Min | -5 431 900% |
| 30th Percentile | -10.9% |
| Median | 0.7% |
| 70th Percentile | 4.2% |
| Max | 251 842.7% |
Other Profitability Ratios
Endexx Corp
Glance View
Endexx Corp. is a diversified holding company, which engages in the plant-based nutraceuticals and emerging technologies. The company is headquartered in Cave Creek, Arizona. The company went IPO on 2001-08-03. Through its subsidiaries, the Company sells CBD oils, capsules, topicals, and pet products, all with the shared purpose of supporting the therapeutic relief of pain and inflammation for humans and pets, through its e-commerce Website, as well as other online and in-store retailers. In addition to its consumer products, its Gorilla-Tek division offers an automated dispensing system providing a method of distributing hemp-based products. The firm also owns and operates a number of wholly-owned subsidiaries that offer technology and consulting solutions to the hemp and CBD industry, including a Seed-to-Shelf compliance and inventory tracking and process management system for regulated products in a front of counter pharmacy support platform. The company formulates and develops products to improve quality of life.
See Also
ROA is calculated by dividing the Net Income by the Avg Total Assets.
The current ROA for Endexx Corp is 112.3%, which is above its 3-year median of 16%.
Over the last 2 years, Endexx Corp’s ROA has increased from -386.9% to 112.3%. During this period, it reached a low of -1 066% on Jun 30, 2022 and a high of 112.3% on Jul 30, 2023.